Skip to main content
Livermore
Livermore
ZHEN

89bio, Inc.

ETNBDelisted Oct 30, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001785173

89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.

13F holders, Q2 2025

Institutional positions in 89bio, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
185
−2 vs. Q1 2025
Shares held
161.2M
+6.86M (+4.4%) vs. Q1 2025
Total value
$1.58B
+$444.2M (+39.0%) vs. Q1 2025
New holders
31
80 more added
Sold out
33
56 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ETNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 185 institutions
Q1 2021: 67 institutionsQ2 2021: 49 institutionsQ3 2021: 48 institutionsQ4 2021: 50 institutionsQ1 2022: 69 institutionsQ2 2022: 70 institutionsQ3 2022: 86 institutionsQ4 2022: 106 institutionsQ1 2023: 147 institutionsQ2 2023: 157 institutionsQ3 2023: 160 institutionsQ4 2023: 153 institutionsQ1 2024: 150 institutionsQ2 2024: 145 institutionsQ3 2024: 144 institutionsQ4 2024: 156 institutionsQ1 2025: 187 institutionsQ2 2025: 185 institutionsQ3 2025: 198 institutionsQ4 2025: 2 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2025: $1.58B
Q1 2021: $400.6MQ2 2021: $315.2MQ3 2021: $339.4MQ4 2021: $226.1MQ1 2022: $64.3MQ2 2022: $104.6MQ3 2022: $227.3MQ4 2022: $589.5MQ1 2023: $1.08BQ2 2023: $1.46BQ3 2023: $1.11BQ4 2023: $1.05BQ1 2024: $1.14BQ2 2024: $828.4MQ3 2024: $773.8MQ4 2024: $948.7MQ1 2025: $1.14BQ2 2025: $1.58BQ3 2025: $2.27BQ4 2025: $1.11MQ1 2026: $0Q2 2026: $0
Institutions holding ETNB and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20252$1.11M
Q3 2025198$2.27B
Q2 2025185$1.58B
Q1 2025187$1.14B
Q4 2024156$948.7M
Q3 2024144$773.8M
Q2 2024145$828.4M
Q1 2024150$1.14B
Q4 2023153$1.05B
Q3 2023160$1.11B
Q2 2023157$1.46B
Q1 2023147$1.08B
Q4 2022106$589.5M
Q3 202286$227.3M
Q2 202270$104.6M
Q1 202269$64.3M
Q4 202150$226.1M
Q3 202148$339.4M
Q2 202149$315.2M
Q1 202167$400.6M

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding 89bio, Inc.; share changes are against Q1 2025.

Institutions holding ETNB in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Corebridge Financial, Inc.0$00.00%−54,823−100.0%Sold out
LMR Partners LLP0$00.00%−50,000−100.0%Sold out
Walleye Capital LLC0$00.00%−44,592−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−34,930−100.0%Sold out
Allostery Investments LP0$00.00%−25,000−100.0%Sold out
SG Americas Securities, LLC0$00.00%−24,865−100.0%Sold out
Gilder Gagnon Howe & Co LLC0$00.00%−19,968−100.0%Sold out
HSBC Holdings PLC0$00.00%−14,940−100.0%Sold out
Ieq Capital, LLC0$00.00%−12,272−100.0%Sold out
CIBC Private Wealth Group, LLC0$00.00%−5,000−100.0%Sold out
FNY Investment Advisers, LLC0$00.00%−3,000−100.0%Sold out
Aster Capital Management (DIFC) Ltd0$00.00%−1,582−100.0%Sold out
Smartleaf Asset Management LLC0$00.00%−304−100.0%Sold out
SRS Capital Advisors, Inc.0$00.00%−84−100.0%Sold out
Amundi0$00.00%−80−100.0%Sold out
Stephens Consulting, LLC0$00.00%−50−100.0%Sold out
Coldstream Capital Management Inc0$00.00%−45−100.0%Sold out
Parallel Advisors, LLC0$00.00%−25−100.0%Sold out